Key result
Chemotherapy and radiation therapy used to treat Hodgkin lymphoma are associated with late adverse effects, including breast cancer and cardiotoxicity, requiring ongoing survivorship care.
Nurses must be familiar with late effects of Hodgkin lymphoma treatments, such as cardiotoxicity, to provide optimal survivorship care.
Nurses should integrate late-effect screening into Hodgkin lymphoma survivorship care; review leaves optimal protocols open for prospective trials.
In Brief The American Cancer Society estimates that in 2014 nearly 16,000 U.S. children and adolescents developed cancer, and in roughly 1,200 of these cases the cancer was Hodgkin lymphoma (HL). The great majority of these patients will survive, joining the thousands who have been diagnosed and treated successfully in decades past. Nurses’ familiarity with and attention to the late effects of the chemotherapy and radiation therapy used to treat HL, which include breast cancer as well as cardiotoxicity and its sequelae, are essential in helping these patients maintain their overall health. The author of this second article in a series on cancer survivorship care from Memorial Sloan Kettering Cancer Center reviews the late adverse effects associated with the management of Hodgkin lymphoma.
No takes yet. Share an insight, caveat, or question.
Joanne Candela (2016) conducted a review in Hodgkin lymphoma. Chemotherapy and radiation therapy was evaluated on Late adverse effects. Chemotherapy and radiation therapy used to treat Hodgkin lymphoma are associated with late adverse effects, including breast cancer and cardiotoxicity, requiring ongoing survivorship care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: